AC Immune and Takeda Sign Exclusive Option and License Agree

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease | Region

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease | Region

eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Japan , Tabeta , Mie , Massachusetts , United States , Osaka , Switzerland , United Kingdom , Japanese , Sarah Sheikh , Gary Waanders , Chris Stamm , Corey Davis , Yuko Yoneyama , Andrea Pfeifer , Chris Maggos Cohesion Bureau , National Institute On Aging Alzheimer Association , Investor Relations Corporate Communications , International Media , Takeda Pharmaceutical Company , Exchange Commission , Securities Exchange , Global Development At Takeda , Takeda Pharmaceutical Company Limited , Neuroscience Therapeutic Area Unit , Global Development , National Institute , Aging Alzheimer , Important Notice , Forward Looking Statements , Annual Report , Securities Act , Securities Exchange Act , Financial Review , Media Contacts , Investor Relations , Business Wire ,